Year: 2020
Sylics starts-up a new location to expand our services and to support your CNS disease research
General
|The ongoing COVID-19 pandemic and again rising infection numbers is affecting all of us personally and our businesses. In this situation, Sylics is focused to continue and expand our support ...
Goudriaan et al. (2020) Cells
References
|Genetic Variation in CNS Myelination and Functional Brain Connectivity in Recombinant Inbred Mice. Goudriaan A, Loos M, Spijker S, Smit AB, Verheijen MHG. Cells. 2020 Sep 18;9(9):2119. doi: 10.3390/cells9092119. PMID: ...
Sylics stands for efficient and high quality drug screening
General
|Tight timelines? Are you in need to have a drug screening study finished before the end of the year to comply with deadlines or your annual budget? At Sylics, we ...
Relevant autism and mental retardation related changes in the Fmr1 knockout mouse
General
|In humans, the absence of the FMR1 protein leads to Fragile X syndrome, mental retardation and neurodevelopmental delays. The Fmr1 knockout mouse model is perceived as highly translational relevant due to the ...
Hoogstraaten et al. (2020) Sci Rep
References
|Tetanus insensitive VAMP2 differentially restores synaptic and dense core vesicle fusion in tetanus neurotoxin treated neurons. Hoogstraaten RI, van Keimpema L, Toonen RF, Verhage M. Sci Rep. 2020 Jul 2;10(1):10913. ...
Vogels et al. (2020) J Alzheimers Dis
References
|Viral Delivery of Non-Mutated Human Truncated Tau to Neurons Recapitulates Key Features of Human Tauopathy in Wild-Type Mice. Vogels T, Vargová G, Brezováková V, Quint WH, Hromádka T. J Alzheimers ...
The 22q11 mouse model available at Sylics shows robust Schizophrenia-relevant deficits
General
|Sylics characterized an accepted model in the field of schizophrenia research based on a microdeletion in the orthologous human 22q11.2 locus. In humans, a microdeletion of the 22q11.2 locus leads ...
Vogels et al. (2020) Biol Psychiatry
References
|Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies. Vogels T, Leuzy A, Cicognola C, Ashton NJ, Smolek T, Novak M, Blennow K, Zetterberg H, Hromadka T, ...
Sylics is comitted to support CNS disease research, also during these challenging times
General
|The outbreak of COVID-19 affects all of us worldwide in an unprecedented manner. This requires us all to prioritize care and take disruptive measures to stop spread of the virus. ...
Stay up-to-date
Sign up for our newsletter and stay up-to-date with the latest news and publications